| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |